Tuesday, July 28, 2026

POWER GRAB: Kim Jong Un Plays ‘Generous Leader’ With Secret Police While His People Starve

Kim Jong Un's visit to North Korea's Ministry of State Security indicates a focus on internal control over dialogue with the U.S. or South Korea.

Is the U.S. Dollar’s Reign Coming to an End? BRICS Might Think So

North Korea has once again advocated for...

Tag: Alteogen

Alteogen CEO Says Additional Licensing Deals Near Completion, Highlights Patent Strength [BIO USA]

Alteogen is nearing global licensing deals, focusing on maximizing value and expanding its platform technology in biopharma.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us